<DOC>
	<DOCNO>NCT02673125</DOCNO>
	<brief_summary>Chromosomal abnormality major cause pregnancy loss . Preimplantation Genetic Screening ( PGS ) use Next Generation Sequencing ( NGS ) allow effective detection abnormality improve clinical outcome . However even transfer chromosomally normal embryo guarantee successful implantation . Recent research Fragouli , et . al . 2015 demonstrate strong association mitochondrial DNA quantity ( also know MitoGradeTM ) implantation outcomes embryos already classified PGS chromosomally normal . Investigators also demonstrate clinical study MitoGradeTM normal PGS normal embryo high chance implantation MitoGrade elevate PGS normal embryo . Transferring MitoGrade elevate PGS normal embryos result le 10 % implantation rate MitoGrade normal PGS normal embryo result 65 % implantation rate . The risk miscarriage replace either type low ( 8 % ) . In order understand complete effectiveness test , investigator conduct paired prospective study . This mean investigator transfer MitoGrade normal MitoGrade elevate embryo time see one implant well . It expect patient join study benefit know least one embryo MitoGrade normal PGS normal .</brief_summary>
	<brief_title>Prospective Paired Study Effectiveness MitoGrade</brief_title>
	<detailed_description>Mitochondria consider powerhouse cell . These membrane-bound organelle play vital role embryonic development essential various cellular function . And unlike cellular organelle , contain DNA ( also know mitochondrial DNA mtDNA ) . Embryonic development complex energy-driven process think highly dependent mitochondrial function mtDNA gene expression . It believe amount mtDNA remain constant first three day preimplantation development . Significant alteration mtDNA initiate day 5 embryo undergone first cellular differentiation trophectoderm ( TE ) inner cell mass . It possible mtDNA variation may account chromosomal abnormality affect accuracy chromosome segregation . In addition describe relationship mtDNA expression clinical outcome , Reprogenetics Fragouli et al . ( 2015 ) able establish threshold clinical pregnancy establish . These result validate prospective blind study independently validate use Next Generation Sequencing ( NGS ) analysis . The quantification mtDNA therefore provide important information select best embryo transfer . MitoGradeTM real-time polymerase chain reaction ( PCR ) base method develop quantify amount mitochondrial DNA ( mtDNA ) present human preimplantation embryo . It believe chromosomally normal embryo MitoGradeTM score lower establish threshold high chance successful implantation comparison similar embryo high MitoGradeTM score .</detailed_description>
	<mesh_term>Infertility</mesh_term>
	<criteria>Center criterion : 1 . Offered clinic &gt; 20 % MitoGrade elevate embryos Patient criterion : 1 . Persons undergo IVF Preimplantation genetic screening ( PGS ) Next Generation Sequencing ( NGS ) eligible part study . 2 . The study limit patient 4 PGSclassified normal embryos 3 . Patients undergo PGS include part study . 4 . Patients undergo PGD ( genetic disorder ) plus PGS exclude . 1 . No specific group individual ( age , ethnicity , egg donation , etc ) exclude .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>Preimplantation Genetic Screening</keyword>
</DOC>